1,537
Views
57
CrossRef citations to date
0
Altmetric
Articles

Cytokines in Sickle Cell Disease

Pages 329-337 | Published online: 04 Sep 2013

References

  • Serjeant, G.R. (1992) Sickle Cell Disease (Oxford University Press, Oxford, England).
  • Bun, H.F. and Forget, B.G. (1986) Hemoglobin: Molecular, Genetic and Clinical Aspects (W.B. Saunders, Philadelphia).
  • Embury, S.H., Hebbel, R.P., Mohandas, N. and Steinberg, M.H. (1994) Sickle Cell Disease: Basic Principles and Clinical Practice (Raven Press, New York, NY).
  • Wang, W.C. and Lukens, J.N. (1999) "Sickle cell anemia and other sickling syndromes", In: Lee, G.R., Foerster, J., Lukens, J., Paraskevas, F., Greer, J.P. and Rodgers, G.M., eds, Wintrobe's Clinical Hematology, 10th Ed. (Williams & Wilkins, Baltimore, Maryland, USA) Vol. 1, pp 1346–1398.
  • Hillery, C.A. (1998) "Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease", Curr. Opin. Hematol. 5, 151–155.
  • Cherry-Peppers, G., Davis, V. and Atkinson, J.C. (1992) "Sickle-cell anemia: a case report and literature review", Clin. Prey. Dent. 14, 5–9.
  • Haynes, J. and Obiako, B. (2002) "Activated polymorpho-nuclear cells increase sickle red blood cell retention in lung: role of phospholipids", Am. J. Physiol. Heart. Circ. Physiol. 282, H122—H130.
  • Dreyer, Z.E. (1996) "Chest infection and syndromes in sickle cell disease of childhood", Semin. Respir. Infect. 11, 163–172.
  • Vichinsky, E.P., Styles, L.A., Colangelo, L.H., Wright, E.C., Castro, O., Nickerson, B. and the Cooperative Study of Sickle Cell Disease (1997) "Acute chest syndrome in sickle cell disease: clinical presentation and course", Blood 89, 1787–1792.
  • Fabry, M.E. and Kaul, D.K. (1991) "Sickle cell vaso-occlusion", Hematol./Oncol. Clin. N. Am. 5, 375–398.
  • Hebbel, R.P. (1997) "Adhesive interactions of sickle erythrocytes with endothelium", J. Clin. Investig. 100, S83—S86.
  • Hebbel, R.P. (1980) "Abnormal adherence of sickle erythro-cytes to cultured vascular endothelium", J. Clin. Investig. 65, 154–160.
  • Swerlick, R., Eckman, J., Kumar, A., Jeitler, M. and Wick, T. (1993) "Alpha 4 beta 1 expression on sickle reticulocytes: vascular cell adhesion molecule 1 dependent binding to the endothelium", Blood 82, 1891–1899.
  • Wun, T., Paglieroni, T., Field, CI., Welborn, J., Cheung, A., Walker, N.J. and Tablin, E (1999) "Platelet-erythrocyte adhesion in sickle cell disease", J. Investig. Med. 47, 121–127.
  • Sugihara, K., Sugihara, T., Mohandas, N. and Hebbel, R.P. (1992) "Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells", Blood 80,2634–2642.
  • Brittain, HA., Eckman, JR., Swerlick, R.A., Howard, R.J. and Wick, T.M. (1993) "Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion", Blood 81, 2137–2143.
  • Joneckis, C.C., Shock, D.D., Cunningham, MI., Orringer, E.P. and Parise, L.V. (1996) "Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombo-spondin under flow conditions", Blood 87, 4862–4870.
  • Lee, S.P., Cunningham, MI., Hines, P.C., Joneckis, C.C., Orringer, E.P. and Parise, L.V. (1998) "Sickle cell adhesion to laminin: potential role for the «5 chain", Blood 92, 2951–2958.
  • Gupta, K., Gupta, P, Solovey, A. and Hebbel, R.P. (1999) "Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin", Biochim. Biophys. Acta 1453, 63–73.
  • Harlan, J.M. (2000) "Anti-adhesion therapy in sickle cell disease", Blood 95, 365–367.
  • Hofrichter, J., Ross, PD. and Eaton, WA. (1974) "Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease", Proc. Natl Acad. Sci. USA 71, 4864–4868.
  • Mozzarelli, A., Hofrichter, J. and Eaton, WA. (1987) "Delay time of hemoglobin S polymerization prevents most cell from sickling in vivo", Science 237, 500–506.
  • Kaul, D.K., Fabry, M.E. and Nagel, R.L. (1986) "Vaso-ocdusion by sickle cells: evidence for selective trapping of dense red cells", Blood 68, 1162–1166.
  • Kaul, D.K., Fabry, M.E. and Nagel, R.L. (1989) "Micro-vascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: patho-physiological implications", Proc. Natl Acad. Sci. USA 86, 3356–3360.
  • Kaul, D.K., Chen, D. and Zhan, J. (1994) "Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells", Blood 83, 3006–3017.
  • Platt, OS., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. and Kinney, T.R. (1991) "Pain in sickle cell disease-rates and risk factors", N. Engl. J. Med. 325, 11–16.
  • Hebbel, R., Boogarets, M., Eaton, J. and Steinberg, M. (1980) "Erythrocyte adherence to the endothelium in sickle cell anemia: a possible determinant of disease severity", N. Engl. J. Med. 302, 992–995.
  • Hebbel, R.P. (2000) "Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies", N. Engl. J. Med. 342, 1910–1911.
  • Hebbel, R.P. and Vercellotti, G.M. (1997) "The endothelial biology of sickle cell disease", J. Lab. Clin. Med. 129,288–293.
  • Stockman, J.A., Nigro, MA., Mishkin, M.M. and Oski, F.A. (1972) "Occlusion of the large cerebral vessels in sickle-cell anemia", N. Engl. J. Med. 287, 846–849.
  • Russell, MO., Goldberg, HI. and Hodson, A. (1984) "Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease", Blood 63, 162–169.
  • Rothman, S.M., Fulling, K.H. and Nelson, J.S. (1986) "Sickle cell anemia and central nervous system infarction: a neuropathological study", Ann. Neurol. 20, 684–690.
  • Blei, E, Fancher, T. and Guarini, L. (1994) "Elevated levels of circulating molecules of potential endothelial origin in sickle cell disease [abstract]", Blood 81(Suppl 1), 409.
  • Sowemimo-Coker, SO., Meiselman, H.J. and Francis, R.B. Jr, (1989) "Increased circulating endothelial cells in sickle cell crisis", Am. J. Hematol. 31, 263–265.
  • George, E, Toulon, P., Sampol, J. and Sultan, Y. (1992) "Detection of high levels of circulating endothelial cells in patients with sickle cell crisis [abstract]", Blood 80( Suppl), 12.
  • Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E. and Hebbel, R.P. (1997) "Circulating activated endothelial cells in sickle cell anemia", N. Engl. J. Med. 337, 1584–1590.
  • Brittain, H.A., Eckman, J.R. and Wick, T.M. (1992) "Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different", J. Lab. Clin. Med. 120, 538–545.
  • Joneckis, C.C., Ackley, R.L., Orringer, E.P., Wayner, E.A. and Parise, L.V. (1993) "Integrin «4131 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia", Blood 82, 3548–3555.
  • Hillery, CA., Du, MC., Montgomery, R.R. and Scott, J.P. (1996) "Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin", Blood 87, 4879–4886.
  • Udani, M., Zen, Q., Coffman, M., Leonard, N., Jefferson, S., Daymont, C., Truskey, G. and Telen, M.J. (1998) "Basal cell adhesion molecule /lutheran protein. The receptor critical for sickle cell adhesion to laminin", J. Clin. Investig. 101, 2550–2558.
  • Pathare, A.V., Al Kindi, S., Alnaqdy, A.A., Mohite, U., Hiwase, D., Dennison, D., Daar, D. and Knox-Macaulay, H.H. (2002) "Cytokine profile of sickle cell disease patients from Oman in acute crisis v/s steady state. [Abst. 3565]", Blood 100, 28h.
  • Harlan, J.M. (1985) "Leukocyte—endothelial interactions", Blood 65, 513–525.
  • Pober, J.S. (1988) "TNF as an activator of vascular endothelium", Ann. Inst. Pasteur. Immun. 193, 317–323.
  • Francis, R., Jr and Haywood, L.J. (1992) "Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease", J. Natl Med. Assoc. 84, 611–615.
  • Malave, I., Perdomo, Y., Escalona, E., Rodriguez, E., Anchustegui, M., Malave, H. and Arends, T. (1993) "Levels of tumor necrosis factor /cachectin (TNFek) in sera from patients with sickle cell disease", Acta Haematol. 90, 172–176.
  • Lipowsky, H.H. and Chien, S. (1989) "Role of leukocyte-endothelium adhesion in affecting recovery from ischemic episodes", Ann. NY Acad. Sci. 565, 308.
  • Croizat, H. (1994) "Circulating cytokines in sickle cell patients during steady state", Br. J. Haematol. 87, 592.
  • Shiu, YT., Udden, M.M. and McIntire, L.V. (2000) "Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells", Blood 95, 3232–3241.
  • Kasschau, M.R., Barabino, G.A., Bridges, K.R. and Golan, D.E. (1993) "Adhesion of sickle neutrophils and erythrocytes to fibronectin", Blood 87, 771–780.
  • Kumar, A., Eckmam, JR., Swerlick, R.A. and Wick, T.M. (1996) "Phorbol ester stimulation increases sickle erythro-cyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin", Blood 88, 4348–4358.
  • Gee, B.E. and Platt, OS. (1995) "Sickle reticulocytes adhere to V-CAM-I", Blood 85, 268–274.
  • Vordermeier, S., Singh, S., Biggerstaff, J., Harrison, P., Grech, H., Pearson, T.C., Dumonde, D.C. and Brown, K.A. (1992) "Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumor necrosis factor (TNF)", Br. J. Hematol. 81, 591–597.
  • Tissot Van Patot, M.C., MacKenzie, S., Tucker, A. and Voelkel, N.F. (1996) "Endotoxin-induced adhesion of red blood cells to pulmonary artery endothelial cells", Am. J. Physiol. 270, 28–36.
  • Sowemimo-Coker, S., Haywood, L.J., Meiselman, H.J. and Francis, R.B. Jr, (1989) "Interleukin-1 increases adherence of normal and sickle erythrocytes to endothelial cells (abstract)", Blood 74( Suppl), 313a.
  • Natarajan, M., Udden, M.M. and McIntire, L.V. (1996) "Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro", Blood 87, 4845–4852.
  • Schroder, J.M. and Christophers, E. (1989) "Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells", J. Immunol. 142, 244–251.
  • Luster, A.D. (1998) "Chemokines- chemotactic cytokines that mediate inflammation", N. Engl. J. Med. 338, 436–445.
  • Hagiwara, T., Suzuki, H., Kono, I., Kashiwagi, H., Akiyama, Y. and Onozaki, K. (1998) "Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepato-cytes", Am. J. Pathol. 136, 39–47.
  • Osborn, L., Hession, C., Tizard, R., Vassalo, C., Luhowsky, J.S., Chi-Rosso, G. and Lobb, R. (1989) "Direct cloning of vascular cell adhesion molecule-I, a cytokine induced endothelial protein that binds to lymphocytes", Cell 59, 1203–1211.
  • Chen, C.C. and Manning, A.M. (1995) "Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-B [review]", Agents Actions Suppl. 47, 135–144.
  • Paszty, C., Brion, C.M., Manci, E., Witkowska, H.E., Stevens, M.E., Mohandas, N. and Rubin, E.M. (1997) "Transgenic knockout mice with exclusive human sickle hemoglobin and sickle cell disease", Science 278, 876–878.
  • Zachlederova, M. and Jarolim, P (2003) "Gene expression profiles of microvascular endothelial cells after stimuli implicated in the pathogenesis of vasoocclusion", Blood Cells, Molecules and Diseases 30, 70–81.
  • Kulcielka, G.L., Hawkins, H.K., Michael, L., et al. (1993) "Regulation of intercellular adhesion molecule 1 (ICAM-1) in ischemic and reperfused canine myocardium", J. Clin. Investig. 92, 1504.
  • Voraberger, G., Schafer, R. and Stratowa, C. (1991) "Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester", J. Immunol. 147, 2777.
  • Cornelius, L.A., Taylor, J.T., Degitz, K., Li, L.J., Lawley, T.J. and Caughman, S.W. (1993) "A 5' portion of the ICAM-1 gene confers tissue-specific differential expression levels and cytokine responsiveness", J. Invest. Dermatol. 100, 753.
  • Iademarco, M.F., McQuillan, J.J., Rosen, G.D. and Dean, D.C. (1992) "Characterization of the promoter for vascular cell adhesion molecule-1", J. Biol. Chem. 267, 16,323.
  • Neish, AS., Williams, A.J., Palmer, H.J., Whitley, M.Z. and Collins, T. (1992) "Functional analysis of the human vascular cell adhesion molecule 1 promoter", J. Exp. Med. 176, 1583.
  • Brittain, J.E., Ivilinar, Kj., Anderson, C.S., Orringer, E.P. and Parise, L.V. (2001) "Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction", J. Clin. Investig. 107, 1555–1562.
  • Browne, P.V., Mosher, D.F., Steinberg, M.H. and Hebbel, R.P. (1996) "Disturbance of plasma and platelet thrombospondin levels in sickle cell disease", Am. J. Hematol. 51, 296–301.
  • Asch, AS., Tepler, I., Sibiger, S. and Nachman, R.I. (1991) "Cellular attachment to thrombospondin. Cooperative interactions between receptors systems", J. Biol. Chem. 266, 1740–1745.
  • Kaul, D.K., Nagel, R.L., Chen, D. and Tsai, H.M. (1993) "Sickle erythrocyte-endothelial interactions in microcircula-tion: the role of von Willebrand factor and implications for vasoocclusion", Blood 81, 2429–2438.
  • Wick, T.M. and Eckman, J.R. (1996) "Molecular basis of sickle cell-endothelial cell interactions", Curr. Opin. Hematol. 3, 118–124.
  • Shetty, N.Y., Rao, A.K. and Stuart, M.J. (2001) "Thrombo-philia in sickle cell disease: the red cell connection", Blood 98, 3228–3233.
  • Wood, B.L., Gibson, D.F. and Tait, J.F. (1996) "Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associa-tions", Blood 88, 1873–1880.
  • Zwaal, R.F.A. and Schroit, A.J. (1997) "Pathophysiologic implications of membrane phospholipid asymmetry in blood cells: a review", Blood 89, 1121–1132.
  • Manodori, A.B., Barabino, GA., Lubin, B.H. and Kuypers, FA. (1999) "Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin", Blood 95, 1293–1300.
  • Belcher, J.D., Marker, PH., Weber, J.P., Hebbel, R.P. and Vercellotti, G.M. (2000) "Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion", Blood 96, 2451–2459.
  • Wun, T., Cordoba, M., Rangaswami, A., Cheung, A.W. and Paglieroni, T. (2002) "Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease", Clin. Lab. Haematol. 24, 81–88.
  • Collins, T. (1993) "Endothelial nuclear factor-KB and the initiation of the atherosclerotic lesion", Lab. Invest. 68, 499–508.
  • Beg, A.A., Ruben, S.M., Scheinman, R.I., Haskill, S., Rosen, C.A. and Baldwin, AS. (1992) "IKB interacts with the nuclear localization sequences of the subunits of NF-KB: a mechanism for cytoplasmic retention", Genes Dev. 6, 1899–1913.
  • Henkel, T., Zabel, U., Van Zee, K., Muller, J.M., Fanning, E. and Baeuerle, P. (1992) "Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-KB subunit", Cell 68, 1121–1133.
  • Solovey, A., Lin, Y, Browne, P., Choong, S., Wayner, E. and Hebbel, R.P. (1997) "Circulating activated endothelial cells in sickle cell anemia", N. Engl. J. Med. 337, 1584–1590.
  • Solovey, A., Gui, L., Key, N.S. and Hebbel, RE (1998) "Tissue factor expression by endothelial cells in sickle cell anemia", J. Clin. Investig. 101, 1899–1904.
  • Springer, T. (1994) "Traffic signals for lymphocyte recircula-tion and leukocyte emigration: the multistep paradigm", Cell 76, 301–314.
  • Carlos, T.M. and Harlan, J.M. (1994) "Leukocyte-endothelial adhesion molecules", Blood 84, 2068–2101.
  • Mann, K.G., van't Veer, C., Cawthern, K. and Butenas, S. (1998) "The role of the tissue factor pathway in initiation of coagulation", Blood Coagul Fibrinolysis 9\(suppl 1), S3—S7.
  • Boghossian, S.H., Nash, G., Dormandy, J. and Bevan, D.H. (1991) "Abnormal neutrophil adhesion in sickle cell anaemia and crisis: relationship to blood rheology", Br. J. Haematol. 78, 437–441.
  • Fadlon, E., Vordermeier, S., Pearson, T.C., Mire-Sluis, A.R., Dumonde, D.C., Phillips, J., Fishlock, K. and Brown, K.A. (1998) "Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64", Blood 91, 266–274.
  • Powars, D.R., Meiselman, J.H., Fishter, T.C., Hiti, A. and Johnson, C. (1994) "Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity", Am. J. Pediatr. Hematol. Oncol. 16, 55–61.
  • Lard, L.R., Mul, F.P., Hass, M., de Roos, D. and Duits, A.J. (1999) "Neutrophil activation in sickle cell disease", J. Leukoc. Biol. 66, 411–415.
  • Duits, Al., Schnog, J.B., Lard, L.R., Saleh, A.W. and Rojer, R.A. (1998) "Elevated IL-8 levels during sickle cell crisis", Fur. J. Haematol. 61, 302–305.
  • Platt, OS., Brambilla, D.J., Rosse, WE, Milner, P.F., Castro, O., Steinberg, M.H. and Klug, P.P. (1994) "Mortality in sickle cell disease: life expectancy and risk factors for early death", N. Engl. J. Med. 330, 1639–1644.
  • Miller, ST., Sleeper, L.A., Pegelow, C.H., Enos, L.E., Wang, W.C., Weiner, S.J., Wethers, D.L., Smith, J. and Kinney, T.R. (2000) "Prediction of adverse outcomes in children with sickle cell disease", N. Engl. J. Med. 342, 83–89.
  • Charache, S. (1997) "Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults", Semin. Hematol. 34, 15–21.
  • Benkerrou, M., Delarche, C., Brahimi, L., Fay, M., Vilmer, E., Elion, J., Gougerot-Pocidalo, M.A. and Elbim, C. (2002) "Hydroxyurea corrects the dysregulated L-selectin expression and increased H202 production of polymorpho-nuclear neutrophils from patients with sickle cell anemia", Blood 99, 2297–2303.
  • Anderson, D.C. and Springer, T.A. (1987) "Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150-95 glycoproteins", Annu. Rev. Med. 38, 175–194.
  • Bevilacqua, M.P. and Nelson, R.M. (1993) "Selectins", J. Clin. Investig. 91, 371–387.
  • Marx, J.L. (1987) "Oxygen free radicals linked to many diseases", Science 235, 529–531.
  • Wun, T. (1998) "Platelet activation in patients with sickle cell disease", Br. J. Hematol. 100, 741–744.
  • Lawler, J. (1986) "The structural and functional properties of thrombospondin", Blood 67, 1197–1209.
  • Su, S.B., Mukaida, N. and Matsushima, K. (1996) "Rapid secretion of intracellular pre-stored interleukin-8 from rabbit platelets upon activation", J. Leukoc. Biol. 59, 420–426.
  • Loppnow, H., Bil, R., Hirt, S., Sconbeck, U., Herzberg, M., Werdan, K., Rietschel, E.T., Brandt, E. and Had, H.D. (1998) "Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells", Blood 91, 134–139.
  • Tomer, A., Eckman, J.R. and Vroon, D.H. (1992) "Platelet activation and procoagulant activity in sickle cell disease (abstract)", Blood 24, 1111.
  • Weyrich, AS., Elstad, M.R., McEver, R.P., McIntyre, T.M., Moore, K.L., Morrissey, J.H., Prescott, S.M. and Zimmerman, G.A. (1996) "Activated platelets signal chemokine synthesis by human monocytes", J. Clin. Investig. 24, 1525–1534.
  • Matsui, N.M., Borsig, L., Rosen, S.D., Yaghmai, M., Varki, A. and Embury, S.H. (2001) "P-selectin mediates the adhesion of sickle erythrocytes to the endothelium", Blood 98, 1955–1962.
  • Lawrence, M.B. and Springer, T.A. (1991) "Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins", Cell 65, 859–873.
  • Matsui, N.M., Varki, A. and Embury, S.H. (2002) "Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin", Blood 100, 3790–3796.
  • Stenberg, P.E., McEver, R.P., Shuman, M.A., Jacques, Y.V. and Bainton, D.E. (1985) "A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation", J. Cell. Biol. 101, 880–886.
  • Hattori, R., Hamilton, K.K., Fugate, RD., McEver, R.P. and Sims, P.J. (1989) "Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribu-tion to the cell surface of the intracellular granule membrane protein GMP-140", J. Biol. Chem. 264, 7768–7771.
  • Lorant, D.E., Patel, K.D., McIntyre, T.M., McEver, R.P., Prescott, S.M. and Zimmerman, G.A. (1991) "Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils", J. Cell Biol. 115, 223–234.
  • Closse, C., Seigneur, M., Renard, M., Pruvost, A., Dumain, P., Belloc, E and Boisseau, M.R. (1996) "Influence of hypoxia and hypoxia-reoxygenation on endothelial P-selectin expression", Haemostasis 26, 177–181.
  • Adams, D.H. and Shaw, S. (1994) "Leucocyte-endothelial interactions and regulation of leucocyte migration", Lancet 343, 831–836.
  • Bach, F.H., Robson, S.C., Winkler, H., Ferran, C., Stuhlmeier, KM., Wrighton, C.J. and Hancock, W.W. (1995) "Barriers to xenotransplantation", Nat. Med. 1, 869–873.
  • Mantovani, A., Sozzani, A., Vecchi, A., Introna, M. and Allvena, P. (1997) "Cytokine activation of endothelial cells: new molecules for an old paradigm", Thromb. Haemost. 78, 406–414.
  • Pober, J.S., Orosz, C.G., Rose, Mi. and Savage, C.O. (1996) "Can graft endothelial cells initiate a host antigraft immune response?", Transplantation 61, 343–349.
  • Kopp, E. and Ghosh, S. (1994) "Inhibition of NF-B by sodium salicylate and aspirin", Science 265, 956–959.
  • Marx, J. (1995) "How the glucocorticoids suppress immu-nity", Science 270, 232–233.
  • Styles, L.A., Lubin, B., Vichinsky, E., Lawrence, M., Hua, M., Test, S. and Kuypers, F. (1997) "Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea", Blood 89, 2544–2559.
  • Bourantas, K.L., Dalekos, G.N., Makis, A., Chaidos, A., Tsiara, S. and Mavrides, A. (1998) "Cytokines and acute-phase proteins during the steady state of sickle cell disease", Fur. J. Hematol. 61, 49–54.
  • Singhal, A., Doherty, IF., Raynes, LG., McAdam, K.P., Thomas, P.W., Serjeant, B.E. and Serjeant, G.R. (1993) "Is there an acute-phase response in steady-state sickle cell disease?", Lancet 341, 651–653.
  • Duits, A.J., Pieters, R.C., Saleh, A.W., van Rosmalen, E., Katerberg, H., Berend, K. and Rojer, R.A. (1996) "Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis", Clin. Immunol. Immunopathol. 81, 96–98.
  • Saleh, A.W., Duits, A.J., Gerbers, A., de Vries, C. and Hillen, H.F. (1998) "Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy", Acta Hematol. 100, 26–31.
  • Kuvibidila, S., Gardner, R., Ode, D., Yu, L., Lane, G. and Warner, R.P. (1997) "Tumor necrosis factor alpha in children with sickle cell disease in stable condition", J. Natl Med. Assoc. 89, 609–615.
  • Solovey, A., Lin, Y., Brown, P., Choong, S., Wayner, E. and Hebbel, R.P. (1997) "Circulating activated endothelial cells in sickle cell anemia", N. Engl. J. Med. 337, 1584–1590.
  • Hedo, C.C., Akinola, Y.A., Okpala, I.E., Durojaiye, A.O. and Sahimonu, L.S. (1993) "Acute phase reactants and severity of homozygous sickle cell disease", J. Intern. Med. 233,467–470.
  • Monnet, D., Diallo, I., Sangare, A. and Yapo, A.E. (1993) "Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease", Bull. Soc. Pathol. Exot. 86, 282–285.
  • Moore, C., Ehlayel, M., Inostroza, J., Leiva, L.E., Kuvibidila, S., Yu, L., Gardner, R., Ode, DL., Warner, R. and Sorensen, R.U. (1998) "Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease", J. Natl Med. Assoc. 90, 157–163.
  • Klug, P.P., Kay, N. and Jensen, W.N. (1982) "Endothelial cell and vascular damage in the sickle cell disorders", Blood Cells 8, 175–184.
  • Nawroyh, P.P., Bank, I., Handley, D., Cassimeris, J., Chess, L. and Stern, D. (1986) "Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1", J. Exp Med. 163, 1363–1367.
  • Baumann, H. and Gauldie, J. (1994) "The acute phase response", Immunol. Today 15, 74–80.
  • Rubycki, A.C., Musto, S., Swinson, G.L., Benjamin, L.J., Nagel, R.L. and Schwartz, R.S. (1991) "Increased levels of endothelin-1 in plasma of sickle cell anemia patients (abstract)", Blood 78, 202a.
  • Hammerman, S.I., Kourembanas, S., Conca, T.J., Tucci, M., Brauer, M. and Farber, H.W. (1997) "Endothehin-1 production during the acute chest syndrome in sickle cell disease", Am. J. Respir. Crit. Care Med. 156, 280–285.
  • Werdehoff, S.G., Moore, R.B., Hoff, C.J., Filhingim, E. and Hackman, A.M. (1998) "Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy", Am. J. Hematol. 58, 195–199.
  • Graido-Gonzahez, E., Doherty, J.C., Bergreen, E.W., Organ, G., Telfer, M. and McMillen, M.A. (1998) "Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis", Blood 92, 2551–2555.
  • Kahaleh, M.B. and Fan, S. (1997) "Effects of cytokines on the production of endothelin by endothelial cells", Chin. Exp. Rheumatol. 15, 163–167.
  • Kruse-Elliott, K.T., VVhorton, A.R. and Olson, N.C. (1998) "Role of lipid-derived mediators in tumor necrosis factor-induced endothehin-1 release in vivo", Shock 9, 40–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.